Sep. 22, 2014, 1:59 PM
- Genetic Technologies (GENE +2.2%) sells its heritage Australian Genetics business to Primary Heath Care Ltd. subsidiary Specialist Services Ltd. for $2M in cash. The Australian Genetics operation provides diagnostic and sequencing services focused on Australia-only medical, forensic, paternity and animal genomic testing.
- The transaction is part of the company's plan to divest non-core assets and focus its activities on the U.S. molecular diagnostics market and its lead breast cancer risk test BREVAGen.
Genetic Technologies Ltd. engages in the business of genetic testing services. The company performs a variety of genetic tests on humans and animals which includes human diagnostics, forensics and animal pedigree tests. It operates through the following segments: Operations, Licensing and... More
Other News & PR